Antigen-specific CD4+ T cells that survive after the induction of peripheral tolerance possess an intrinsic lymphokine production defect

Novartis Found Symp. 1998:215:103-13; discussion 113-9, 186-90. doi: 10.1002/9780470515525.ch8.

Abstract

Injection of soluble foreign antigen without an adjuvant induces a state of antigen-specific immunological unresponsiveness. We investigated the cellular mechanisms that underlie this form of peripheral tolerance by physically tracking a small population of ovalbumin (OVA) peptide/I-Ad-specific, CD4+ T cell receptor (TCR) transgenic T cells following adoptive transfer into normal recipients. Injection of OVA peptide in the absence of adjuvant caused the antigen-specific T cells to proliferate for a brief period after which most of the T cells disappeared. The remaining OVA-specific T cells had converted to a memory phenotype but were poorly responsive in vivo as evidenced by a failure to accumulate in the draining lymph nodes following immunization with OVA peptide in adjuvant. These surviving T cells possessed a long-lasting, but reversible, defect in Il-2 and TNF-alpha production and in vivo proliferation, but did not gain capacity to produce Th2-type cytokines or suppress the clonal expansion of T cells specific for another antigen. Therefore, some antigen-specific T cells survive this peripheral tolerance protocol but are functionally unresponsive due to an intrinsic activation defect.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • CD4-Positive T-Lymphocytes / immunology*
  • Immune Tolerance*
  • Immunologic Memory
  • Interleukin-2 / biosynthesis*
  • Models, Immunological
  • Ovalbumin / immunology
  • Peptide Fragments / immunology
  • Tumor Necrosis Factor-alpha / biosynthesis*

Substances

  • Interleukin-2
  • Peptide Fragments
  • Tumor Necrosis Factor-alpha
  • Ovalbumin